Bulletin
Investor Alert

London Markets Open in:

Company Close Updates Archives | Email alerts

Jan. 27, 2021, 5:06 p.m. EST

BioNTech SE ADR outperforms market despite losses on the day

new
Watchlist Relevance
LEARN MORE

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

or Cancel Already have a watchlist? Log In

MarketWatch Automation

The BioNTech SE ADR BNTX shed 0.30% to $105.97 Wednesday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index SPX falling 2.57% to 3,750.77 and Dow Jones Industrial Average DJIA falling 2.05% to 30,303.17. This was the ADR's second consecutive day of losses. BioNTech SE ADR closed $25.03 short of its 52-week high ($131.00), which the company reached on December 11th.

Despite its losses, the ADR outperformed some of its competitors Wednesday, as AbbVie Inc. ABBV fell 5.52% to $102.79 and Amgen Inc. AMGN fell 2.92% to $251.06. Trading volume (2.1 M) remained 2.0 million below its 50-day average volume of 4.1 M.

Editor's Note: This story was auto-generated by Automated Insights using data from Dow Jones and FactSet. See our market data terms of use.

This Story has 0 Comments
Be the first to comment
More News In
Markets

Story Conversation

Commenting FAQs »

Partner Center

Link to MarketWatch's Slice.